Хуудас 1 -аас 22 үр дүн
TECHNICAL FIELD
The present invention relates to the field of anti-aging of skin. Specifically, the invention relates to novel compositions and methods of using the compositions for effacing and preventing wrinkles in mammalian skin.
BACKGROUND OF THE INVENTION
Skin is subject to abuse by many
CROSS REFERENCE TO RELATED APPLICATIONS AND CLAIM OF PRIORITY
This patent application is a National Stage entry from International Application No. PCT/KR2013/007420, filed Aug. 19, 2013, which claims priority to Korean Patent Application No. 10-2012-0089857, filed Aug. 17, 2012, entire contents of
TECHNICAL FIELD
This invention relates to treatment of neurodegenerative disorders, and more particularly to Alzheimer's disease and Parkinson's disease.
BACKGROUND
Oxidative stress plays a role in neurodegeneration, regardless of etiology. Physical trauma or secondary effects of insult to the
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention generally relates to a method and composition for the alleviation of eye diseases and, more specifically, to an improved method and composition for combating macular degeneration.
2. Description of the Related Art
Macular
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention generally relates to methods and compositions to alleviate eye diseases and, more specifically, to improved methods and compositions for the treatment of cataracts and macular degeneration.
2. Description of the Related
BACKGROUND
Cancer is a major public health problem in the United States and other parts of the world. Currently, 1 in 4 deaths in the United States is due to cancer. Angiogenesis plays a critical role in tumor growth and metastasis in most types of cancer. In particular, its importance has been
INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ELECTRONICALLY
This application contains a sequence listing. It has been submitted electronically via EFS-Web as an ASCII text file entitled "111232-00408_ST25.txt". The sequence listing is 16,384 bytes in size, and was created on Jul. 20, 2015. It is
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the fields of neurobiology and developmental biology. More specifically, the present invention relates to the identification of novel neuregulin splice variant isoforms.
2. Description of the Related
FIELD OF THE INVENTION
This invention relates to a wheat flour which is used in preparing fresh (undried) noodles, dried noodles and tenobe somen (hand-made thin wheat noodles) and a process for producing the same. More particularly, the present invention relates to a process for suppressing or
FIELD OF THE INVENTION
The present invention relates to compounds that act as specific inhibitors of the cysteine protease dipeptidyl peptidase I (DP I). Compounds based on acylated hydroxamates are distinguished by being chemically stable in aqueous solutions, including biological fluids (Bromme
BACKGROUND OF THE INVENTION
This invention is in the fields of pharmacology and biochemistry. It relates to the synthesis of certain complexes of L-cysteine, N-acetyl L-cysteine, N-(2-mercapto-propionyl)glycine, L-2-oxothiazolidine-4-carboxylate and the nutritional or clinical use of these and other
BACKGROUND OF THE INVENTION
This invention is in the fields of pharmacology and biochemistry. It relates to the synthesis of certain complexes of L-cysteine, N-acetyl L-cysteine, N-(2-mercapto-propionyl)glycine, L-2-oxothiazolidine-4-carboxylate and the nutritional or clinical use of these and other
This invention relates to compositions and processes that maintain the integrity of fruit that generally exhibits loss of color, loss of texture, and changes in flavor or aroma when cut, and is more specifically related to compositions and processes that are effective in preventing the
BACKGROUND OF THE INVENTION
The present invention relates to a novel ovoglycoprotein and an agent for chromatographic separation and more specifically to an ovoglycoprotein having optical recognizability and an agent serving as a fixed phase for chromatographic separation comprising a carrier and
TECHNICAL FIELD
The present invention relates to an angiogenesis inhibitor comprising a cysteine protease inhibitory compound.
BACKGROUND OF THE INVENTION
An angiogenesis is a phenomenon wherein new blood vessels are created to form a new vascular network in the living body. The angiogenesis is